Product Program year 2025 Source: CMS Open Payments

Benefix

Biological Hematology

NDC 58394-633-03

Open in the dashboard

General payments

$154,859

2,032 payments

Research payments

$450,922

150 payments

Through program year 2025, $154,859 in general payments and $450,922 in research payments were reported against Benefix (Hematology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

12 rows
Year Kind Amount Payments
2025 General $39,562 801
2025 Research $24,990 13
2024 General $21,889 348
2024 Research $41,120 72
2023 General $17,551 319
2023 Research $21,260 33
2022 General $8,317 259
2022 Research $50,170 27
2021 General $8,085 92
2020 General $16,370 123
2019 General $43,085 90
2019 Research $313,382 5

Breakdown

Who paid General payments · program years 2019–2025
  1. Pfizer Inc. $148,571 1,679 payments
  2. PBG Puerto Rico LLC $6,233 350 payments
  3. Pfizer Pharmaceuticals LLC $54 3 payments
Top recipients General payments · program year 2025
  1. University Of Kansas Hospital Teaching hospital · KS $6,000 15% · 2 payments
  2. Ryan Laduke Physician Assistant · Rochester, NY $4,655 12% · 2 payments
  3. Craig Seaman Hematology · Pittsburgh, PA $4,200 11% · 2 payments
  4. Tampa General Hospital Teaching hospital · FL $2,950 7% · 1 payment
  5. Henry Ford Hospital Teaching hospital · MI $2,000 5% · 1 payment

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Hematology & Oncology Internal Medicine $5,507 20% · 153 practitioners
  2. Physician Assistant $5,221 19% · 19 practitioners
  3. Hematology Internal Medicine $4,692 17% · 11 practitioners
  4. Pediatric Hematology-Oncology Pediatrics $2,717 10% · 76 practitioners
  5. Nurse Practitioner, Family Nurse Practitioner $2,179 8% · 70 practitioners

The top 5 of 52 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Kansas $6,749 17% · 27 recipients
  2. New York $4,856 12% · 13 recipients
  3. Pennsylvania $4,295 11% · 5 recipients
  4. Florida $3,568 9% · 24 recipients
  5. Michigan $2,473 6% · 16 recipients

The top 5 of 34 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

Given in the clinic

Part B · billing code
Medicare Part B billing codes matched to BENEFIX
Billing code Providers Services Paid by Medicare
Injection, factor ix (antihemophilic factor, recombinant) per iu, not otherwise specified J7195 2 3,739,916 $5,269,124

Drugs given by a clinician are billed to Medicare Part B, not Part D. The product is tied to a billing code through the NDC on CMS's crosswalk, which was published for a later quarter than the payments, so a code that changed in between can be missed. Providers with fewer than 11 patients for the code are not published. Medicare's payment here is what it paid for the services, to the billing practice.

2,032 general · 150 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record